


期刊介绍
Therapeutic Advances in Chronic Disease (TACD) is a peer-reviewed open access journal which focuses on the highest quality research, reviews and scholarly comment on pioneering efforts and innovative studies across all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers, providing a forum in print and online for publishing the highest quality articles in this area. Please see the Aims and Scope tab for further information.
慢性病治疗进展(TACD)是一本经过同行评审的开放获取期刊,着重于对所有慢性病的开 拓性努力和创新研究进行最高质量的研究,评论和学术性评论。该杂志着重于临床和药理 学领域,面向临床医生和研究人员,提供印刷和在线论坛,以出版该领域最优质的文章。 请查看“目标和范围”标签以获取更多信息。
全名/缩写 | /Therapeutic Advances in Chronic Disease |
期刊ISSN | 2040-6223 |
2022-2023影响因子 | 3.500 实时影响因子查询 (由greensci.net提供-2019 New!) |
最新自引率 | 0.00 |
期刊官方网站 | |
是否OA开放访问 | |
出版国家或地区 | |
出版年份 | 0 |
中科院JCR分区 | 大类:小类: |
SCI期刊coverage | Science Citation Index Expanded(科学引文索引扩展) |
审稿速度(网友添加,非官方) |
×
绿色通道审稿 加急发表
可添加微信号:meibisi123